Search results
AbbVie (ABBV) Gains As Market Dips: What You Should Know
Zacks via Yahoo News· 3 weeks agoThe most recent trading session ended with AbbVie (ABBV) standing at $169.91, reflecting a +1.05%...
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Zacks via Yahoo News· 3 weeks agoAbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
The Zacks Analyst Blog Highlights Novo Nordisk, AbbVie, AstraZeneca, Air T and United-Guardian
Zacks via Yahoo News· 3 weeks agoFor Immediate Release Chicago, IL – July 11, 2024 – Zacks.com announces the list of stocks featured...
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
Zacks via Yahoo News· 3 weeks agoWith the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to...
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
Zacks via Yahoo News· 3 weeks agoThe traditional ways to plan for your retirement may mean income can no longer cover expenses...
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo News· 3 weeks agoFor Immediate Releases Chicago, IL – July 8, 2024 – Zacks.com announces the list of stocks featured...
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
Zacks via Yahoo News· 1 month agoThis week, the FDA rejected Merck's MRK and AbbVie’s ABBV regulatory filings seeking approvals for...
AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
Zacks via Yahoo News· 1 month agoAbbVie's (ABBV) acquisition of Celsius Therapeutics is set to add the latter's lead pipeline...
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
Zacks via Yahoo News· 1 month agoDesigned to provide broad exposure to the Health Care ETFs category of the market, the Invesco...
Merck's (MRK) Lung Cancer Candidate Faces FDA Rejection
Zacks via Yahoo News· 1 month agoThe FDA's CRL to Merck (MRK) and its partner Daiichi Sankyo for the patritumab deruxtecan BLA is...